Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli Lilly and Company (NYSE:LLY) even as it fell into a bear market after peaking in August.

Eli Lilly agreed on Friday ... increase on its recent trading levels. Lilly’s interest in Dermira lies mainly with interleukin-13 inhibitor lebrikizumab, which is in a pair of phase 3 trials ...

This is nearly 23% cheaper than the auto-injectors costing $650, which are often not covered by insurance. Eli Lilly's president, Patrik Jonsson, noted that over 10% of patients have begun using the ...

Eli Lilly LLY-2.01%decrease; red down pointing triangle is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using their health plans ...

Eli Lilly & Co. said Tuesday that it has launched new doses of its obesity treatment drug and reduced its prices. The pharmaceutical company said it has launched 7.5 and 10 milligram single-dose ...

Eli Lilly (NYSE:LLY) began offering vials of the two lowest doses of Zepbound, which is typically sold in auto-injector pens, in August last year. On Tuesday, it said it had cut the prices for a ...